Linked Data API

Show Search Form

Search Results

1285210
registered interest false more like this
date less than 2021-02-09more like thismore than 2021-02-09
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans his Department has to commission a long term study of immune responses in people vaccinated against covid-19. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 151854 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-03-05more like thismore than 2021-03-05
answer text <p>Public Heath England’s surveillance strategy monitor how effective the vaccine is at protecting against a range of outcomes, including infection, symptomatic disease, hospitalisations, mortality, and onwards transmission. The surveillance strategy is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy</a></p><p>The National Institute for Health Research (NIHR) and the UK Research and Innovation are jointly funding the UK Coronavirus Immunology Consortium to address key questions around the immune system’s response to COVID-19. The NIHR’s Health Protection Research Unit in Respiratory Infections is also looking at the size and longevity of the immune response.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-03-05T14:16:12.83Zmore like thismore than 2021-03-05T14:16:12.83Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1285211
registered interest false more like this
date less than 2021-02-09more like thismore than 2021-02-09
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of different covid-19 vaccines on different age groups. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 151855 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-02-19more like thismore than 2021-02-19
answer text <p>Public Health England is leading on the surveillance of the COVID-19 vaccine programme and has developed a surveillance strategy to monitor the effectiveness of COVID-19 vaccines against mortality, hospitalisations, confirmed infections, markers of infectiousness and the impact on transmission.</p><p> </p><p>Whilst phase three clinical trials provided evidence of vaccine effectiveness against symptomatic disease, further evidence is needed on how effectiveness varies by subgroup, including by age. This will be done using advanced surveillance techniques once the earliest eligible cohorts have been offered a full course of vaccination.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
grouped question UIN
151688 more like this
151745 more like this
151889 more like this
question first answered
less than 2021-02-19T10:40:36.62Zmore like thismore than 2021-02-19T10:40:36.62Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1285212
registered interest false more like this
date less than 2021-02-09more like thismore than 2021-02-09
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS Covid Pass more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the limitations of vaccine passports for people who have been vaccinated against covid-19. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 151856 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-03-31more like thismore than 2021-03-31
answer text <p>The Government will review whether COVID-19 status certification could play a role in reopening the economy, reducing restrictions on social contact and improving safety. This will include assessing to what extent certification would be effective in reducing risk and the potential uses to enable access to settings or a relaxation of COVID-19 secure mitigations. The Government will also consider the ethical, equalities, privacy, legal and operational aspects of this approach and what limits, if any, should be placed on organisations using certification. It will draw on external advice to develop recommendations that take into account any social and economic impacts and implications for disproportionately impacted groups and individuals’ privacy and security. The review will also include consideration of potential solutions for people to access their COVID-19 vaccination status.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-03-31T09:13:23.357Zmore like thismore than 2021-03-31T09:13:23.357Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1281088
registered interest false more like this
date less than 2021-01-27more like thismore than 2021-01-27
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Vaccination: Manufacturing Industries more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what his Department’s plans are to increase the UK’s vaccine manufacturing capacity to meet future demand. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 144846 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-02-05more like thismore than 2021-02-05
answer text <p>The Government has invested over £300 million to secure and scale-up the UK’s manufacturing capabilities to be able to respond to the pandemic, including:</p><p>a) Facilities that have come online:</p><ul><li>£4.7 million for skills training through the Advanced Therapies Skills Training Network, which will be delivered through both virtual and physical centres;</li><li>£8.75 million for the set-up of the rapid deployment facility at Oxford Biomedica in Oxfordshire;</li><li>£65.5 million for the early manufacture of the University of Oxford / AstraZeneca vaccine;</li><li>Fill and finish through a contract with Wockhardt in Wrexham, North Wales which is currently providing fill-finish capabilities to the University of Oxford / AstraZeneca vaccine; and</li><li>The expansion of the Valneva factory in Livingston, Scotland, which will also provide longer-term UK capacity.</li></ul><p>b) Facilities that will come online later this year, to help provide longer term UK capacity:</p><ul><li>£93 million to accelerate the completion and expanded role of the Vaccines Manufacturing Innovation Centre in Oxfordshire; and</li><li>£127 million for the Cell and Gene Therapy Catapult in Braintree, Essex.</li></ul>
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-02-05T13:15:05.107Zmore like thismore than 2021-02-05T13:15:05.107Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1281090
registered interest false more like this
date less than 2021-01-27more like thismore than 2021-01-27
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Coronavirus: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support research into new SARS-CoV-2 variants. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 144847 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-02-05more like thismore than 2021-02-05
answer text <p>UK Research and Innovation (UKRI) has invested nearly £500 million towards 2,200 new research and innovation initiatives, both in the UK and globally. These initiatives are diverse and include research into new SARS-CoV-2 variants.</p><p> </p><p>The University of Liverpool is part of a new national research project to study the effects of emerging mutations in SARS-CoV-2. Supported by £2.5 million of funding from UKRI, the G2P-UK National Virology Consortium will study how mutations in the virus affect key outcomes. This includes factors such as how transmissible the virus is, the severity of COVID-19 caused, and the effectiveness of vaccines and treatments.</p><p> </p><p>The Consortium will bring together leading virologists from 10 research institutions including the University of Liverpool. The university will work alongside the COVID-19 Genomics UK (COG-UK) consortium, which plays a world-leading role in virus genome sequencing, as well as Public Health England, to boost the UK's capacity to study newly identified virus variants and rapidly inform the Government’s policy.</p><p> </p><p>The current overall UKRI portfolio of COVID-19-related grants, including awards supported by Innovate UK, involves vaccine projects that provide greater diversity of approaches than for the first generation of vaccines developed. More details can be found on the UKRI website.</p>
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-02-05T13:18:21.33Zmore like thismore than 2021-02-05T13:18:21.33Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1260539
registered interest false more like this
date less than 2020-12-11more like thismore than 2020-12-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the (a) economic and (b) societal effects of medical treatments are taken into account when assessing medicines, in the context of the approval and procurement of covid-19 vaccine candidates. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 128731 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-04-13more like thismore than 2021-04-13
answer text <p>The Government has accepted the recommendations from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to authorise three COVID-19 vaccines for use - Pfizer/BioNTech, Oxford/AstraZeneca and Moderna. While this approval is not specifically on the basis of economic and societal benefits, it is on the grounds of patient safety. No vaccine would be deployed in the United Kingdom unless the expected standards of safety, quality and efficacy are met.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-04-13T15:27:35.617Zmore like thismore than 2021-04-13T15:27:35.617Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this
1216029
registered interest false more like this
date less than 2020-06-22more like thismore than 2020-06-22
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Department for Business, Energy and Industrial Strategy: Public Inquiries more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will publish the (a) statutory and (b) non-statutory public inquiries being undertaken by his Department. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson remove filter
uin 62605 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-06-30more like thismore than 2020-06-30
answer text <p>The non-statutory Magnox Inquiry is currently underway, which is an independent inquiry into the award of the Magnox decommissioning contract by the Nuclear Decommissioning Authority and its subsequent termination.</p><p> </p><p>Once convened, public inquiries are run independently of the Government. The Department supports and cooperates fully with all public inquiries as required.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2020-06-30T08:43:37.25Zmore like thismore than 2020-06-30T08:43:37.25Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this